General Information of Drug Transporter (DT)
DT ID DTD0335 Transporter Info
Gene Name SLC38A8
Transporter Name Putative sodium-coupled neutral amino acid transporter 8
Gene ID
146167
UniProt ID
A6NNN8
Post-Translational Modification of This DT
Overview of SLC38A8 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X: Amino Acid

Phosphorylation

  Serine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A8 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

157

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A8 Serine 157 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A8 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

165

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A8 Serine 165 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A8 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

152

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A8 Threonine 152 has the potential to affect its expression or activity.
References
1 Fast Global Phosphoproteome Profiling of Jurkat T Cells by HIFU-TiO2-SCX-LC-MS/MS. Anal Chem. 2017 Sep 5;89(17):8853-8862.
2 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.